4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Clariant AG (CLN) operates in the Specialty Chemicals industry and is headquartered in Muttenz, Switzerland with about 10,107 employees. Its market capitalization is roughly CHF 4 billion. In the fiscal year ended 2025-12-31, CLN reported CHF 3.9B in revenue and (CHF 75M) in net income.
Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. It operates through Care Chemicals, Catalysts, and Adsorbents & Additives segments.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CHF 3.9B | CHF 4.2B | CHF 4.4B | CHF 5.2B | — |
| Gross Profit | CHF 1.2B | CHF 1.3B | CHF 1.1B | CHF 1.0B | — |
| Operating Income (EBIT) | CHF 311M | CHF 385M | CHF 240M | CHF 31M | — |
| Net Income | (CHF 75M) | CHF 244M | CHF 134M | CHF 84M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CHF 138M) | (CHF 139M) | (CHF 138M) | (CHF 132M) | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CHF 5.9B | CHF 6.3B | CHF 5.3B | CHF 6.2B | — |
| Total Liabilities | CHF 3.7B | CHF 3.8B | CHF 3.2B | CHF 3.7B | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CLN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms